Skip to main content
. 2015 May 18;2015:854706. doi: 10.1155/2015/854706

Table 2.

Distribution of lymphocyte populations in peripheral blood of pSS patients and controls.

Patients 1I-controls 2II-pSS Abs 3III-pSS Abs+ P * P * P *
I-II I-III II-III
Main lymphocyte populations
 CD3+ T cells
  %4 75.36 ± 6.93 72.16 ± 9.81 73.03 ± 8.47 NS NS NS
  A. count# 2530 ± 811.0 2154 ± 1133 1868 ± 1052 0.027 0.0002 NS
 CD4+ T cells
  %4 49.33 ± 9.12 46.20 ± 8.49 39.37 ± 12.39 NS 0.0036 0.036
  A. count# 1688 ± 654.9 1391 ± 804.3 1089 ± 975.4 0.015 <0.0001 0.01
 CD8+ T cells
  %4 26.73 ± 7.29 26.25 ± 8.82 29.87 ± 11.64 NS NS NS
  A. count# 939 ± 326.4 760.5 ± 433.5 690.2 ± 259.6 0.014 0.006 NS
 B cells
  %4 11.86 ± 4.43 13.82 ± 9.13 14.52 ± 5.15 NS 0.045 NS
  A. count# 401.3 ± 216.5 351.2 ± 197.8 393.5 ± 294.1 NS NS NS
 NK
  %4 12.19 ± 5.67 12.99 ± 6.84 12.10 ± 6.05 NS NS NS
  A. count# 415.4 ± 186.7 365.7 ± 210.7 306.1 ± 201.7 NS 0.036 NS
 NKT
  %4 6.79 ± 4.26 8.44 ± 8.51 6.36 ± 5.86 NS NS NS
  A. count# 223.4 ± 132.0 206.7 ± 168.6 137.7 ± 127.1 NS 0.009 NS

1I group: healthy controls; 2II group: pSS patients without anti-SSA/SSB; 3III group: pSS patients with anti-SSA and/or anti-SSB; %4: proportion of all CD4+ lymphocytes; A. count#: absolute count of cells in 1 μL of blood. *Mann-Whitney test. NS: not significant.